ECKERT & ZIEGLER BG 
By Seneffe, 11 June 2012 - Today Susanne Becker and Dr. Michael Friebe were elected as new Members to the Eckert & Ziegler BEBIG Board of Directors at its Annual Shareholders' Meeting. They are replacing outgoing members Holger Bürk, Hans-Jörg Hinke, Dick Schoolenberg und Edwin Vandermeulen as the size of the Board of Directors is being reduced to eight members.
Susanne Becker is an attorney and works as an advisor in the Labor Market Division of the Confederation of German Employers' Associations in Berlin (BDA).
Dr. Friebe is Managing Director of m2f investment, a venture capital company for start-ups in the life sciences sector, as well as id+tm, a consulting company that specializes in medical technology. For almost 20 years in his capacity as founder and investor, he has started numerous companies in the field of medical imaging. In addition, Dr. Friebe is Chairman of the Supervisory Board of SurgicEye GmbH and an Advisory Board Member of Curefab GmbH in Munich, as well as a lecturer at the Technical University Munich.
"On behalf of the Board of Directors, I would like to thank the outgoing members for their faithful and committed service during the last years. We would also like to welcome the new Members to the Board of Directors and look forward to a successful collaboration," said Dr. Andreas Eckert, Chairman of the Board of Directors.
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry. Its core business is the treatment of cancer using brachytherapy, a special form of radiation therapy.
Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters are in Belgium, with a production facility in Germany and subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.
The company's products and equipment are intended for use by oncologists, radiologists, urologists, and medical physicists.
Eckert & Ziegler BEBIG employs more than 150 people. The company has been listed on the Euronext stock exchange since April 1997 (Euronext: EZBG; Reuters: EZBG.BR; Bloomberg: EZBG:BB).
For further information, please contact:
Karolin Riehle, Investor Relations
Tel.: +32 (0) 64 520 808, ir@bebig.eu:
mailto:ir@bebig.eu, www.bebig.eu:
http://www.bebig.eu/
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: Eckert & Ziegler BEBIG via Thomson Reuters ONE
